Trials / Completed
CompletedNCT01154543
Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes
A Single Center, Open Label, Longitudinal Single Arm Study to Compare the Efficacy and Safety of Prophylactic Famciclovir 500 mg b.d. in HIV Positive Adults With Recurrent Genital Herpes.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (actual)
- Sponsor
- Holdsworth House Medical Practice · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy of Famvir 500mg bd as suppressive antiviral therapy for acute genital Herpes simplex virus (HSV) outbreaks in HIV subjects.
Conditions
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2013-01-01
- Completion
- 2013-02-01
- First posted
- 2010-07-01
- Last updated
- 2013-03-20
Source: ClinicalTrials.gov record NCT01154543. Inclusion in this directory is not an endorsement.